Pfizer, Inc. (PFE) Tops Q1 EPS by 2c; Cuts FY12 Outlook
Tweet
Share
E-mail
Get Alerts PFE Hot Sheet
Price: $26.21 +0.15%
Revenue Growth %: -1.8%
Financial Fact:
Research and development expenses: 1.88B
Today's EPS Names:
PLCE, COE, JVA, More
Revenue Growth %: -1.8%
Financial Fact:
Research and development expenses: 1.88B
Today's EPS Names:
PLCE, COE, JVA, More
Join SI Premium – FREE
Pfizer, Inc. (NYSE: PFE) reported Q1 EPS of $0.58, $0.02 better than the analyst estimate of $0.56. Revenue for the quarter came in at $15.4 billion versus the consensus estimate of $15.47 billion.
Sees FY12 adj-EPS of $2.14-$2.24 on sales of $58-$60 billion. The Street is currently expecting FY12 EPS of $2.26 on sales of $62.14 billion. Pfizer had previously guided FY12 adj-EPS to $2.20-$2.30 on sales of $60.5-$62.5 billion.
For earnings history and earnings-related data on Pfizer, Inc. (PFE) click here.
Sees FY12 adj-EPS of $2.14-$2.24 on sales of $58-$60 billion. The Street is currently expecting FY12 EPS of $2.26 on sales of $62.14 billion. Pfizer had previously guided FY12 adj-EPS to $2.20-$2.30 on sales of $60.5-$62.5 billion.
For earnings history and earnings-related data on Pfizer, Inc. (PFE) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Nvidia pitches Vera CPU to Chinese clients with August delivery target
- BIG3 Basketball to go public via Graf Global merger at $290 million
- Adobe Systems (ADBE) Tops Q2 EPS by 14c, Offers Guidance
Create E-mail Alert Related Categories
Earnings, Guidance, Hot Guidance, Hot ListRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
